Vestal Point Capital, LP - Sep 30, 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: LXEO
Shares outstanding: 54.9M shares
Disclosed Ownership: 4.12M shares
Ownership: 7.5%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:00 PM
Date of event: Sep 30, 2025
Previous filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	7.5%	4.12M	0	4.12M	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	7.5%	4.12M	0	4.12M	/s/ Ryan Wilder	Ryan Wilder, Individually